HORIZONS-AMI

The Lancet

Volumn 375, Issue 9712, 2010, Pages 375-

  Webster, Mark WI ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; THIENOPYRIDINE DERIVATIVE;

ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; FEMORAL ARTERY; HEART INFARCTION; HUMAN; LETTER; LOADING DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RADIAL ARTERY; ST SEGMENT ELEVATION; STENT THROMBOSIS; UNSPECIFIED SIDE EFFECT;

EID: 75149119339     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60163-8     Document Type: Letter

References (5)

1. Mehran R., Lansky A.J., and Witzenbichler B. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 374 (2009) 1149-1159
2. Stone G.E., Witzenbichler B., Guagliumi G., et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008) 2218-2230
3. Mehilli J., Kastrati A., Schulz S., et al. Abciximab in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 119 (2009) 1933-1940
4. Le May M.R., Wells G.A., Glover C.A., et al. Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST). Circulation Cardiovasc Intervent 2 (2009) 330-338
5. Jolly S.S., Amlani S., Hamon M., Yusuf S., and Mehta S.R. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 157 (2009) 132-140